follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      HomeAuthorsAnkit Singhania

      Articles by Ankit Singhania

      Ankit Singhania
      Based in India, Ankit is a financial content writer and stock market analyst. He has worked for almost a decade on several financial projects related to the stock market news, fundamental research and technical analysis for several websites. He obtained his Masters Degree In finance (MS – finance) from ICFAI. Currently, he serves as a financial consultant and technical analyst at Tradersinsights.com.
      ACHN stock
      Biotechnology

      ACHN Stock Extends Rally: Soars 55% in 2 Sessions

      Jul 23 Ankit Singhania
      ACHN stock has been on a roll for two days straight after Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced positive updates from the Phase 1 study of its product ACH-5228, an experimental oral factor D inhibitor. ACHN ... [Read]
      TRNX stock
      Oil & Gas

      TRNX Stock Doubles After $165 Million Landmark Deal in Turkey

      Jul 22 Ankit Singhania
      TRNX stock has been one of the biggest gainers in the market today in early morning trade as it climbed by as much as 97%. Investors flocked to Taronis Technologies (NASDAQ:TRNX) following the publication of ... [Read]
      JCP stock
      Retail

      JCP Stock Tumbles 15% on Reports of Debt Restructuring Options

      Jul 19 Ankit Singhania
      JCP stock is taking a hit and fell over 15% on a report from Reuters that JC Penney (NYSE:JCP) is in talks with advisers on debt restructuring options Ballooning Debts American departmental store chain JC ... [Read]
      CODX stock
      Medical

      CODX Stock Doubles as CoPrimer Detects Cancer Successfully

      Jul 18 Ankit Singhania
      CODX stock is the biggest gainer on the Nasdaq after Co-Diagnostics Inc (NASDAQ:CODX) announced favorable results from a study to detect cancer mutations using its CoPrimer technology. Key Development Molecular diagnostics company Co-Diagnostics Inc, which ... [Read]
      APRN stock
      Retail

      APRN Stock Extends Rally Thanks to Beyond Meat, Up 50% This Week

      Jul 17 Ankit Singhania
      APRN stock continues to move higher for the second straight session after rising over 35% in yesterday’s trading session. Stock Rebound on Big News Plant-based meat manufacturing company Beyond Meat (NASDAQ:BYND) has proven to be ... [Read]
      WKHS stock
      Autos

      WKHS Stock Extends Rally, Up 55% in One Month

      Jul 16 Ankit Singhania
      WKHS stock has been gaining momentum since the beginning of this year. Let’s take a look at the key developments. WKHS Stock Up 55% in One Month Workhorse Group Inc (NASDAQ:WKHS), which is involved in ... [Read]
      CAPR stock
      Biotechnology

      CAPR Stock Jumps to New 2019 Highs on Positive CAP-1002 Outcomes

      Jul 15 Ankit Singhania
      CAPR stock is moving up big as Capricor Therapeutics Inc (NASDAQ:CAPR) announces positive data in a rare disease indication. Big News for Capricor California-based Capricor Therapeutics has been one of the biggest gainers today after ... [Read]
      MDGS stock
      Medical

      MDGS Stock Rockets 50% on a Major Order Announcement

      Jul 12 Ankit Singhania
      Medical device manufacturing company Medigus Limited (NASDAQ:MDGS) is the talk of the market on Friday morning as MDGS stock surged by as much as 50% following the announcement that it had bagged a substantial order ... [Read]
      BBBY stock
      Retail

      BBBY Stock Tumbles to 21-Year Low Amid Deteriorating Earnings Growth

      Jul 11 Ankit Singhania
      BBBY stock is having one of the worst of worst trading sessions on Thursday as the giant retailer Bed Bath & Beyond Inc. (NASDAQ:BBBY) reported a second consecutive quarter of net loss. Revenue Falls The ... [Read]
      VISL stock
      Communications

      VISL Stock Jumps Big on a New Contract From US Army

      Jul 10 Ankit Singhania
      VISL stock is the biggest gainer in today’s session with a rise of a whopping 320% after Vislink Technologies Inc (NASDAQ:VISL) announced that it has reached a $2.80 million deal with the US Army. Solid ... [Read]

      Posts pagination

      « 1 … 19 20 21 … 27 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Subscribe & Get FREE Achillion Pharmaceuticals Email Alerts
      Get FREE Achillion Pharmaceuticals Email Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      x